Morgan Stanley
LGHT icon

Morgan Stanley’s Langar Global HealthTech ETF LGHT Stock Holding History

Morgan Stanley’s Portfolio LGHT Stock Details LGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.5K Sell
7,324
-1,466
-17% -$12.3K ﹤0.01% 6428
2026
Q1 		$76.5K Buy
+8,790
New +$84.5K ﹤0.01% 6262

Other funds holding LGHT

I
INVST Indianapolis, Indiana $1.03B AUM 29.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley's LGHT Position: Q2 2026 in Review

Morgan Stanley reduced its Langar Global HealthTech ETF (LGHT) stake by 17% in Q2 2026, selling an estimated $12.3K and leaving 7,324 shares worth $62.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6428.

Morgan Stanley first reported a position in LGHT in Q1 2026 and has held it in 2 quarters since. The position peaked at $76.5K in Q1 2026. 3 funds tracked by Wall St. Rank hold LGHT as of Q2 2026.

  • Morgan Stanley held 7,324 shares of Langar Global HealthTech ETF worth $62.5K as of Q2 2026.
  • Morgan Stanley sold 1,466 Langar Global HealthTech ETF shares in Q2 2026, an estimated $12.3K.
  • Langar Global HealthTech ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6428 holding.
  • Morgan Stanley first reported a position in Langar Global HealthTech ETF in Q1 2026 and has held it in 2 quarters since.
  • Morgan Stanley's Langar Global HealthTech ETF position peaked at $76.5K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Langar Global HealthTech ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.